Expression and function of inducible costimulator on peripheral blood CD4+ T Cells in Behçet's Patients with Uveitis: A new activity marker?

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5099-5104

  Usui, Yoshihiko ^a,b   Takeuchi, Masaru ^a   Yamakawa, Naoyuki ^a   Takeuchi, Aya ^a   Kezuka, Takeshi ^a   Ma, Juan ^a   Matsuda, Ryusaku ^a   Okunuki, Yoko ^a   Akiba, Hisaya ^b   Goto, Hiroshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; B7 RELATED PROTEIN 1; CD28 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INDUCIBLE COSTIMULATOR; INTERLEUKIN 17; INTERLEUKIN 6; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; B7-RELATED PROTEIN-1; BIOLOGICAL MARKER; BLOCKING ANTIBODY; CYTOKINE; EYE PROTEIN; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; INTERSTITIAL RETINOL-BINDING PROTEIN; MESSENGER RNA; RETINOL BINDING PROTEIN; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REMISSION; UVEITIS; COMPARATIVE STUDY; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TH1 CELL;

ADULT; ANTIBODIES, BLOCKING; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BEHCET SYNDROME; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CONCANAVALIN A; CYTOKINES; EYE PROTEINS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOL-BINDING PROTEINS; RNA, MESSENGER; TH1 CELLS; UVEITIS;

EID: 77958141178     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5286     Document Type: Article

References (51)

1. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol. 1993;77:584-589.
2. O'Duffy JD. Behçet's disease. Curr Opin Rheumatol. 1994;6:39-43.
3. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996-1002.
4. Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702-3708.
5. Kitaichi N, Kotake S, Sasamoto Y, et al. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci. 1999;40:247-250.
6. de Smet MD, Dayan M. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls. Invest Ophthalmol Vis Sci. 2000;41:3480-3484.
7. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42:1967-1974.
8. Zhao C, Yang P, He H, et al. S-antigen specific T helper type 1 response is present in Behçet's disease. Mol Vis. 2008;14:1456-1464.
9. Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49: 3058-3064.
10. Choi SC, Kim KD, Kim JT, et al. Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity. J Leukoc Biol. 2008; 83:89-98.
11. Caspi RR, Sun B, Agarwal RK, et al. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye. 1997;11:209-212.
12. Hirose S, Tanaka T, Nussenblatt RB, et al. Lymphocyte responses to retinal-specific antigens in uveitis patients and healthy subjects. Curr Eye Res. 1988;7:393-402.
13. Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB. S-antigen uveitis in primates: a new model for human disease. Arch Ophthalmol. 1981;99:1090-1092.
14. Chambers CA. The expanding world of co-stimulation: the twosignal model revisited. Trends Immunol. 2001;22:217-223.
15. Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol. 2001;2:203-209.
16. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225-252.
17. Chitnis T, Najafian N, Abdallah KA, et al. CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest. 2001;107:575-583.
18. Silver PB, Hathcock KS, Chan CC, Wiggert B, Caspi RR. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance. J Immunol. 2000;165:5041-5047.
19. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397:263-266.
20. Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 1999;402:827-832.
21. Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity. 1999;11:423-432.
22. Aicher A, Hayden-Ledbetter M, Brady WA, et al. Characterization of human inducible costimulator ligand expression and function. J Immunol. 2000;164:4689-4696.
23. Bauquet AT, Jin H, Paterson AM, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol. 2009;10:167-175.
24. Dong C, Juedes AE, Temann UA, et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 2001; 409:97-101.
25. Tafuri A, Shahinian A, Bladt F, et al. ICOS is essential for effective T-helper-cell responses. Nature. 2001;409:105-109.
26. Ozkaynak E, Gao W, Shemmeri N, et al. Importance of ICOSB7RP- 1 costimulation in acute and chronic allograft rejection. Nat Immunol. 2001;2:591-596.
27. Rottman JB, Smith T, Tonra JR, et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol. 2001;2:605-611.
28. Iwai H, Kozono Y, Hirose S, et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol. 2002;169:4332-4339.
29. Schaefer JS, Montufar-Solis D, Vigneswaran N, Klein JR. ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10-/- mice. J Leukoc Biol. 2010;87(2):301-308.
30. Usui Y, Akiba H, Takeuchi M, et al. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis. Eur J Immunol. 2006;36:3071-3081.
31. Xing L, Yang P, Wu C, et al. Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol. 2006;244(12):1650-1658.
32. Shao H, Fu Y, Liao T, et al. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Invest Ophthalmol Vis Sci. 2005;46:596-603.
33. Bagenstose LM, Agarwal RK, Silver PB, et al. Disruption of CD40/ CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance. J Immunol. 2005;175:124-130.
34. Namba K, Ogasawara K, Kitaichi N, et al. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody. J Immunol. 2000;165:2962-2969.
35. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol. 2002;20:29-53.
36. Fujimori K, Oh-i K, Takeuchi M, et al. Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246:285-290.
37. Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest Ophthalmol Vis Sci. 2002;43:2791-2798.
38. Fukai T, Okada AA, Sakai J, et al. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol. 1999; 237:928-933.
39. Redmond TM, Wiggert B, Robey FA, et al. Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, a unique extracellular matrix component of the retina. Biochemistry. 1985;24:787-793.
40. Takeuchi M, Usui Y, Okunuki Y, et al. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behçet's patients with uveitis. Invest Ophthalmol Vis Sci. 2010;51(6):3067-75.
41. Iwai H, Abe M, Hirose S, et al. Involvement of inducible costimulator- B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol. 2003;171:2848-2854.
42. Totsuka T, Kanai T, Iiyama R, et al. Ameliorating effect of antiinducible costimulator monoclonal antibody in a murine model of chronic colitis. Gastroenterology. 2003;124:410-421.
43. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205:799-810.
44. Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin Immunopathol. 2008;30:135-143.
45. de Smet MD, Yamamoto JH, Mochizuki M, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1990;110:135-142.
46. Raziuddin S, al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S. Divergent cytokine production profile in Behçet's disease: altered Th1/Th2 cell cytokine pattern. J Rheumatol. 1998;25:329-333.
47. Zhang R, Qian J, Guo J, Yuan YF, Xue K. Suppression of experimental autoimmune uveoretinitis by anti-IL-17 antibody. Curr Eye Res. 2009;34:297-303.
48. Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC. Adamantiades- Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology. 2000;201:37-39.
49. Itoh R, Takenaka T, Okitsu-Negishi S, Matsushima K, Mizoguchi M. Interleukin 8 in Behçet's disease. J Dermatol. 1994;21:397-404.
50. Kawamoto M, Harigai M, Hara M, et al. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Arthritis Res Ther. 2006;8:R62.
51. Yang JH, Zhang J, Cai Q, et al. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005;44:1245-1254.